Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vascular Microenvironment, Tumor Immunity and Immunotherapy
Zachary L Lamplugh, Yi Fan
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Heterogeneity of the tumor immune microenvironment and its clinical relevance
Qingzhu Jia, Aoyun Wang, Yixiao Yuan, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 130
Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1143-1143
Open Access | Times Cited: 53
Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism
Fan Yang, Gloria Lee, Yi Fan
Angiogenesis (2024) Vol. 27, Iss. 3, pp. 333-349
Open Access | Times Cited: 21
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer
Shan Liu, Xingda Zhang, Wenzheng Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Research progress on tumor hypoxia-associative nanomedicine
Xiaoxue Xu, Siyi Chen, Ningbo Yi, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 829-840
Closed Access | Times Cited: 54
Application of bismuth sulfide based nanomaterials in cancer diagnosis and treatment
Zhongwei Yang, Longwei Wang, Jian Zhang, et al.
Nano Today (2023) Vol. 49, pp. 101799-101799
Closed Access | Times Cited: 27
A metal-organic framework (MOF) built on surface-modified Cu nanoparticles eliminates tumors via multiple cascading synergistic therapeutic effects
Guanghui An, Heming Zheng, Lianshan Guo, et al.
Journal of Colloid and Interface Science (2024) Vol. 662, pp. 298-312
Closed Access | Times Cited: 14
An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma
Fan Yang, Md. Naushad Akhtar, Duo Zhang, et al.
Science Advances (2024) Vol. 10, Iss. 9
Open Access | Times Cited: 13
Exosome miR-199a-5p modulated vascular remodeling and inflammatory infiltration of Takayasu’s arteritis
Shuning Guo, Jiehan Li, Shurui Pang, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access | Times Cited: 1
Clinical efficacy and safety of sintilimab plus oral vinorelbine as first-line treatment for newly diagnosed stage IIIB–IV nonsmall cell lung cancer patients with performance status 2 or age ≥75 years
Wenzhong Su, Jianqiang Li
Anti-Cancer Drugs (2025)
Closed Access | Times Cited: 1
Exosomes and cancer immunotherapy: A review of recent cancer research
Yue Cao, Peng Xu, Yangling Shen, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 18
Targeting hypoxic and acidic tumor microenvironment by nanoparticles: A review
Mohamed J. Saadh, Mohammed Ahmed Mustafa, Laith Yassen Qassem, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105660-105660
Closed Access | Times Cited: 8
Current status and prospects of gelatin and its derivatives in oncological applications: Review
Yingfeng Zhang, Jia Wang
International Journal of Biological Macromolecules (2024) Vol. 274, pp. 133590-133590
Open Access | Times Cited: 6
The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma
Huiyang Yuan, Xin Qin, Jing Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Immunomodulatory Properties of Immune Checkpoint Inhibitors—More than Boosting T-Cell Responses?
Michael Kuske, Maximilian Haist, T. Jung, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1710-1710
Open Access | Times Cited: 24
Recent advances in vascularized tumor-on-a-chip
Christina Bao Xian Huang, Ting‐Yuan Tu
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
Detection, mechanisms, and therapeutic implications of oncometabolites
Ying Cai, Zhibo Wang, Sifan Guo, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 12, pp. 849-861
Closed Access | Times Cited: 14
Ultrasound Imaging of Tumor Vascular CD93 with MMRN2 Modified Microbubbles for Immune Microenvironment Prediction
Dingyi Wang, Changyang Xing, Yuan Liang, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Closed Access | Times Cited: 6
Spatial analysis of tissue immunity and vascularity by light sheet fluorescence microscopy
Duo Zhang, Abigail H. Cleveland, Elisavet Krimitza, et al.
Nature Protocols (2024) Vol. 19, Iss. 4, pp. 1053-1082
Closed Access | Times Cited: 5
Blood Vessel-Targeted Therapy in Colorectal Cancer: Current Strategies and Future Perspectives
Anne Jacobsen, Jürgen Siebler, Robert Grützmann, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 890-890
Open Access | Times Cited: 5
Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression
Syazalina Zahari, Saiful Effendi Syafruddin, M. Aiman Mohtar
Cancers (2023) Vol. 15, Iss. 9, pp. 2653-2653
Open Access | Times Cited: 12
Advances in Nanoplatforms for Immunotherapy Applications Targeting the Tumor Microenvironment
Nannan Zhang, Junyu Zhou, Shun Li, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 4
Understanding organotropism in cancer metastasis using microphysiological systems
Jihoon Ko, Jiyoung Song, Yedam Lee, et al.
Lab on a Chip (2024) Vol. 24, Iss. 6, pp. 1542-1556
Open Access | Times Cited: 4
Effectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study
Xue-Jun Dou, Run-Yang Ma, De-Wang Ren, et al.
Lung Cancer Targets and Therapy (2024) Vol. Volume 15, pp. 29-40
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top